Display options
Cite
Cheng DL, Zhu N, Li CL, et al. Significance of malondialdehyde, superoxide dismutase and endotoxin levels in Budd-Chiari syndrome in patients and a rat model. Exp Ther Med. 2018;16(6):5227-5235doi: 10.3892/etm.2018.6835.
Cheng, D. L., Zhu, N., Li, C. L., Lv, W. F., Fang, W. W., Liu, Y., & Li, C. T. (2018). Significance of malondialdehyde, superoxide dismutase and endotoxin levels in Budd-Chiari syndrome in patients and a rat model. Experimental and therapeutic medicine, 16(6), 5227-5235. https://doi.org/10.3892/etm.2018.6835
Cheng, De-Lei, et al. "Significance of malondialdehyde, superoxide dismutase and endotoxin levels in Budd-Chiari syndrome in patients and a rat model." Experimental and therapeutic medicine vol. 16,6 (2018): 5227-5235. doi: https://doi.org/10.3892/etm.2018.6835
Cheng DL, Zhu N, Li CL, Lv WF, Fang WW, Liu Y, Li CT. Significance of malondialdehyde, superoxide dismutase and endotoxin levels in Budd-Chiari syndrome in patients and a rat model. Exp Ther Med. 2018 Dec;16(6):5227-5235. doi: 10.3892/etm.2018.6835. Epub 2018 Oct 09. PMID: 30542478; PMCID: PMC6257749.
Copy Download .nbib Format: NLM
Share it on

Exp Ther Med. 2018 Dec;16(6):5227-5235. doi: 10.3892/etm.2018.6835. Epub 2018 Oct 09.

Significance of malondialdehyde, superoxide dismutase and endotoxin levels in Budd-Chiari syndrome in patients and a rat model.

Experimental and therapeutic medicine

De-Lei Cheng, Nan Zhu, Cheng-Li Li, Wei-Fu Lv, Wei-Wei Fang, Ya Liu, Chuan-Ting Li

Affiliations

  1. Department of Magnetic Resonance Imaging, Shandong Medical Imaging Research Institute, Shandong University, Jinan, Shandong 250021, P.R. China.
  2. Department of Interventional Radiology, Anhui Provincial Hospital, Hefei, Anhui 230001, P.R. China.
  3. Department of Radiology, People's Hospital of Wuhe County, Bengbu, Anhui 233300, P.R. China.
  4. Department of Interventional Radiology, The Third People's Hospital of Hefei, Hefei, Anhui 230022, P.R. China.

PMID: 30542478 PMCID: PMC6257749 DOI: 10.3892/etm.2018.6835

Abstract

Budd-Chiari syndrome (BCS) is a rare clinical syndrome caused by the obstruction of hepatic venous outflow. In theory, hepatic congestion and hypoxia induce pathological damage and changes in the liver. However, at present, laboratory evidence supporting this theory is lacking. The aim of the present study was to assess the expression and significance of the hypoxia-associated indicators malondialdehyde (MDA), superoxide dismutase (SOD) and endotoxin (ET) in the liver and serum of subjects with BCS. An animal model of BCS was established by partial ligation of the inferior vena cava (IVC) in rats. The levels of MDA, SOD and ET in the serum of BCS patients, as well as in the liver and serum of rats with BCS, were detected and analyzed. In human patients with BCS, the serum levels of MDA, ET and SOD were significantly different from those in healthy control subjects. In the animal model, similar trends were observed regarding the MDA, ET and SOD levels in liver homogenate and serum (P<0.05), the degree of which was more pronounced in the liver homogenate than in the serum. At 6 weeks after the surgery, these indicators reached peak/valley levels in the experimental group and were at least partially restored by week 12. A negative correlation between MDA and SOD, a positive correlation between MDA and ET, and a negative correlation between SOD and ET was identified. In conclusion, the levels of hypoxia-associated indicators significantly changed with BCS progression, suggesting that hypoxia is a major factor in the pathogenesis of BCS.

Keywords: Budd-Chiari syndrome; endotoxin; hypoxia; reactive oxygen species

References

  1. J Hepatol. 1999 Mar;30(3):433-9 - PubMed
  2. J Clin Transl Hepatol. 2016 Sep 28;4(3):263-268 - PubMed
  3. Lung India. 2017 Jul-Aug;34(4):324-329 - PubMed
  4. World J Hepatol. 2014 Jan 27;6(1):41-54 - PubMed
  5. BMC Gastroenterol. 2015 Jul 08;15:77 - PubMed
  6. Hepatobiliary Pancreat Dis Int. 2011 Jun;10(3):254-60 - PubMed
  7. EXCLI J. 2011 Dec 08;10:290-302 - PubMed
  8. Biol Chem. 2017 Oct 26;398(11):1209-1227 - PubMed
  9. United European Gastroenterol J. 2015 Dec;3(6):489-500 - PubMed
  10. Liver Int. 2011 Nov;31(10):1432-48 - PubMed
  11. Intractable Rare Dis Res. 2015 Feb;4(1):24-32 - PubMed
  12. World J Gastroenterol. 2014 Aug 14;20(30):10628-36 - PubMed
  13. Int Immunopharmacol. 2016 Jun;35:272-279 - PubMed
  14. Chem Biol Interact. 2009 Jun 15;180(1):20-30 - PubMed
  15. World J Gastroenterol. 2007 Apr 7;13(13):1912-27 - PubMed
  16. Dig Dis Sci. 2017 Oct;62(10):2801-2811 - PubMed
  17. J Surg Res. 2008 Aug;148(2):116-20 - PubMed
  18. Redox Biol. 2015;4:158-68 - PubMed
  19. Heart Asia. 2011 Jan 01;3(1):143-9 - PubMed
  20. World J Gastroenterol. 2007 May 21;13(19):2693-6 - PubMed
  21. Curr Med Chem. 2012;19(28):4850-60 - PubMed
  22. Front Physiol. 2017 Feb 13;8:84 - PubMed
  23. Int J Clin Exp Pathol. 2015 May 01;8(5):4651-61 - PubMed
  24. Int J Mol Sci. 2015 Nov 02;16(11):26087-124 - PubMed
  25. World J Gastroenterol. 2014 Nov 21;20(43):16236-44 - PubMed
  26. Basic Res Cardiol. 2016 May;111(3):26 - PubMed
  27. J Ethnopharmacol. 2011 Dec 8;138(3):683-90 - PubMed

Publication Types